EFFICACY OF TWO AYURVEDA DRUG REGIMENS FOR UTERINE FIBROIDS, A RANDOMIZED, SINGLE BLIND, THREE-ARM, CLINICAL TRIAL-STUDY PROTOCOL

被引:0
|
作者
Karunagoda, Kaumadi [1 ]
Perera, Pathirage Kamal [2 ]
Senanayake, Hemantha [3 ]
机构
[1] Univ Colombo, Dept Ayurveda Obstet Gynecol & Pediat, Rajagiriya, Sri Lanka
[2] Univ Colombo, Dept Ayurveda Pharmacol & Pharmaceut, Inst Indigenous Med, Rajagiriya, Sri Lanka
[3] Univ Colombo, Fac Med, Dept Obstet & Gynecol, Rajagiriya, Sri Lanka
关键词
Uterine fibroids; Treatment regimen; Ayurveda; UFS-QOL; Prakriti;
D O I
10.13040/IJPSR.0975-8232.10(3).1366-71
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Uterine fibroids are the most common genital tract tumor in reproductive age women. The main treatment option for fibroid is surgical intervention. Options for medical therapy are currently limited to preoperative reduction of symptoms related to uterine bleeding and fibroid size. Ayurveda treatment for this condition is widely practiced in Sri Lanka. We aimed to evaluate the efficacy of two Ayurveda treatment regimes in patients with uterine fibroids. The study is designed as a randomized, single blind, three arm clinical study with 30 participants in each arm. Participants diagnosed with uterine fibroids size 2 cm or more and meet the inclusion criteria are enrolled to this study. Arm I and Arm II undergo two Ayurveda treatment regimens and Arm III is the control group. Endpoint will be calculated from baseline in volume of the largest fibroid by two dimension ultrasound scan after 12 weeks of treatment intervention and repeat in four weeks follow up. Clinical improvements and quality of life is assessed by Uterine Fibroid Symptom and Health-Related Quality of Life Questionnaire (UFS-QOL). Effect of therapy on each arm is assessed based on the Ayurveda body constitution (Prakriti). Haematological investigations are conducted before and after the treatment as safety parameters. Statistical analysis will be done using SPSS version 16. All statistical tests will be performed, two-tailed with significance determined by reference to the 5% level. Outcome of this study will be to developed evidence-based effective alternative to standard methods of treating uterine fibroids.
引用
收藏
页码:1366 / 1371
页数:6
相关论文
共 50 条
  • [31] Comparison of Two Theory-Based, Fully Automated Telephone Interventions Designed to Maintain Dietary Change in Healthy Adults: Study Protocol of a Three-Arm Randomized Controlled Trial
    Wright, Julie A.
    Quintiliani, Lisa M.
    Turner-McGrievy, Gabrielle M.
    Migneault, Jeffrey P.
    Heeren, Timothy
    Friedman, Robert H.
    JMIR RESEARCH PROTOCOLS, 2014, 3 (04):
  • [32] Mental Health Chatbot for Young Adults With Depressive Symptoms During the COVID-19 Pandemic: Single-Blind, Three-Arm Randomized Controlled Trial
    He, Yuhao
    Yang, Li
    Zhu, Xiaokun
    Wu, Bin
    Zhang, Shuo
    Qian, Chunlian
    Tian, Tian
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2022, 24 (11)
  • [33] Clinical Efficacy of Megadose Vitamin C in Sepsis: Protocol for a Multicenter Randomized Single-Blind Placebo-Controlled Clinical Trial
    Guizhong Wang
    Zhihui Liang
    Jianbin Guan
    Ping Chang
    Zhenhua Zeng
    Jianwei Li
    Shaowu Chen
    Zhanguo Liu
    Intensive Care Research, 2024, 4 (2): : 129 - 136
  • [34] Study protocol for safety and efficacy of all-oral shortened regimens for multidrug-resistant tuberculosis: a multicenter randomized withdrawal trial and a single-arm trial [SEAL-MDR]
    Liang Fu
    Juan Xiong
    Haibo Wang
    Peize Zhang
    Qianting Yang
    Yi Cai
    Wenfei Wang
    Feng Sun
    Xilin Zhang
    Zhaoqin Wang
    Xinchun Chen
    Wenhong Zhang
    Guofang Deng
    BMC Infectious Diseases, 23
  • [35] Study protocol for safety and efficacy of all-oral shortened regimens for multidrug-resistant tuberculosis: a multicenter randomized withdrawal trial and a single-arm trial [SEAL-MDR]
    Fu, Liang
    Xiong, Juan
    Wang, Haibo
    Zhang, Peize
    Yang, Qianting
    Cai, Yi
    Wang, Wenfei
    Sun, Feng
    Zhang, Xilin
    Wang, Zhaoqin
    Chen, Xinchun
    Zhang, Wenhong
    Deng, Guofang
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [36] Study Protocol of a Multicenter, Randomized, Single-Blind Trial: Efficacy and Safety of Remimazolam Tosylate for Sedation in ICU Patients
    Liu, Ning
    Jiang, Zhiyi
    Nie, Yao
    Zuo, Lingyun
    Chen, Chuanxi
    Si, Xiang
    Liu, Qin
    Chen, Minying
    Guan, Xiangdong
    ADVANCES IN THERAPY, 2023, 40 (05) : 2524 - 2533
  • [37] Study Protocol of a Multicenter, Randomized, Single-Blind Trial: Efficacy and Safety of Remimazolam Tosylate for Sedation in ICU Patients
    Ning Liu
    Zhiyi Jiang
    Yao Nie
    Lingyun Zuo
    Chuanxi Chen
    Xiang Si
    Qin Liu
    Minying Chen
    Xiangdong Guan
    Advances in Therapy, 2023, 40 : 2524 - 2533
  • [38] Tolerability, exposure and pharmacokinetics in healthy subjects of a Chinese herbal medicine MaZiRenWan (MZRW): Study protocol for a randomized open-labelled, three-arm phase 0/1 clinical trial
    Zhong, Linda L. D.
    Kun, Wai
    Zhao, Ling
    Lin, Cheng Yuan
    Huang, Tao
    Bian, Zhao Xiang
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2016, 8 (04) : 581 - 586
  • [39] Combining compensatory cognitive training and medication self-management skills training, in inpatients with schizophrenia: A three-arm parallel, single-blind, randomized controlled trial
    Zhu, Xiaodan
    Song, Hong
    Chang, Ru
    Chen, Bing
    Song, Yuanyuan
    Liu, Juan
    Wang, Kefang
    GENERAL HOSPITAL PSYCHIATRY, 2021, 69 : 94 - 103
  • [40] GAP (gestational diabetes and pharmacotherapy)-study protocol for a randomized controlled, two-arm, single-site trial
    Palatnik, Anna
    Saffian, Eleanor
    Flynn, Kathryn E.
    Pan, Amy Y.
    Yee, Lynn M.
    Basir, Mir Abdul
    Cruz, Meredith
    CONTEMPORARY CLINICAL TRIALS, 2023, 131